Evidence map›Paper›PMID 15706226›Full record

ArticleNeuroreport2005

Dystrophin Dp71 in PC12 cell adhesion.

Jose Arturo Enríquez-Aragón, Joel Cerna-Cortés, Mario Bermúdez de León, Francisco García-Sierra, Everardo González, Dominique Mornet, Bulmaro Cisneros

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neuroreport, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Dp71 Expression in Human Glioblastoma.International journal of molecular sciences · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Jose Arturo Enríquez-AragónDepartment of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del IPN, 07360 México, D. F., México.
Joel Cerna-Cortés
Mario Bermúdez de León
Francisco García-Sierra
Everardo González
Dominique Mornet
Bulmaro Cisneros
Instituto de Estudios Avanzados · VEInstituto Politécnico Nacional · MXUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, we reported that PC12 cells with decreased Dp71 expression (antisense-Dp71 cells) display deficient nerve-growth-factor-induced neurite outgrowth. In this study, we show that disturbed neurite outgrowth of antisense-Dp71 cells is accompanied by decreased adhesion activity on laminin, collagen and fibronectin. In wild-type cells, the immunostaining of Dp71 and beta1-integrin overlaps in the basal area contacting the substrate, but staining of both proteins decrease in the antisense-Dp71 cells. Morphology of antisense-Dp71 cells at the electron microscopic level is characterized by the lack of filopodia, cellular projections involved in adhesion. Our findings suggest that Dp71 is required for the efficient PC12 cell attachment to beta1-integrin-dependent substrata and that decreased adhesion activity of the antisense-Dp71 cells could determine their deficiency to extend neurites.

Indexed as

AnimalsCell AdhesionCell DifferentiationCollagenDystrophinFibronectinsFluorescent Antibody TechniqueIntegrin beta ChainsLamininMicroscopy, Electron, ScanningNeuritesOligodeoxyribonucleotides, AntisensePC12 CellsRatsStatistics, Nonparametricapo-dystrophin 1CollagenDystrophinFibronectinsIntegrin beta ChainsLamininOligodeoxyribonucleotides, Antisense

Identifiers

PMID15706226
PMCPMC2494584
OpenAlexW2075966130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.